Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03313011 · ClinicalTrials.gov registry record
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
A clinical trial of Primary Progressive Aphasia and Apraxia of Speech, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 47
- Enrollment target
- 1
- Study location
NCT03313011 is a study of Primary Progressive Aphasia and Apraxia of Speech that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 47 participants, below the 90-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03313011, a study of Primary Progressive Aphasia and Apraxia of Speech, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Testing protocol for the study
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2027-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03313011
The ClinicalTrials.gov registry entry for NCT03313011 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 15 other Primary Progressive Aphasia trials with a reported enrollment target (48% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Primary Progressive Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Testing protocol for the study is the first listed.
NCT03313011 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03313011 about?
NCT03313011 is a clinical study titled "The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech". The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.
What is the current status of trial NCT03313011?
This trial is currently recruiting. The enrollment target is 47 participants. The study started on 2017-08-01. Estimated completion is 2027-07.
What conditions does trial NCT03313011 study?
This clinical trial studies the following conditions: Primary Progressive Aphasia, Apraxia of Speech, Non-fluent Aphasia, Primary Progressive Nonfluent Aphasia.
What interventions are being tested in trial NCT03313011?
The interventions under investigation include: Testing protocol for the study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03313011?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03313011 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Progressive Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
RECRUITING · Phase 4
-
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
RECRUITING · Phase 2
-
Language in Primary Progressive Aphasia
RECRUITING
-
Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia
RECRUITING · Early Phase 1
-
Enhancing Language Function in Aphasia
RECRUITING · NA
-
Enhancing Language Function in Primary Progressive Aphasia
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.